First Nebraska Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Sell
85,056
-1,849
-2% -$398K 1.66% 13
2025
Q4
$17.9M Sell
86,905
-1,551
-2% -$292K 1.63% 12
2025
Q3
$13.9M Sell
88,456
-153
-0.2% -$23.6K 1.26% 19
2025
Q2
$14.9M Sell
88,609
-785
-0.9% -$117K 1.43% 15
2025
Q1
$12.3M Sell
89,394
-731
-0.8% -$93.2K 1.22% 20
2024
Q4
$10.7M Buy
90,125
+1,080
+1% +$126K 1.03% 23
2024
Q3
$9.84M Buy
89,045
+7,177
+9% +$750K 0.96% 27
2024
Q2
$8.05M Sell
81,868
-497
-0.6% -$50.6K 0.83% 34
2024
Q1
$9.22M Sell
82,365
-1,163
-1% -$125K 0.95% 27
2023
Q4
$8.42M Buy
83,528
+3,720
+5% +$369K 0.97% 27
2023
Q3
$6.93M Buy
79,808
+225
+0.3% +$20.3K 0.86% 31
2023
Q2
$7.53M Sell
79,583
-337
-0.4% -$28.5K 0.9% 29
2023
Q1
$6.03M Sell
79,920
-123
-0.2% -$9.28K 0.76% 30
2022
Q4
$6.15M Sell
80,043
-560
-0.7% -$42.6K 0.8% 31
2022
Q3
$5.37M Buy
80,603
+1,675
+2% +$106K 0.77% 32
2022
Q2
$4.13M Buy
78,928
+3,030
+4% +$172K 0.54% 41
2022
Q1
$4.3M Buy
75,898
+17,525
+30% +$939K 0.51% 42
2021
Q4
$3.01M Sell
58,373
-22,756
-28% -$1.12M 0.36% 55
2021
Q3
$4.01M Buy
81,129
+2,738
+3% +$149K 0.53% 41
2021
Q2
$4.48M Buy
78,391
+3,150
+4% +$184K 0.58% 39
2021
Q1
$4.57M Buy
75,241
+6,657
+10% +$367K 0.61% 38
2020
Q4
$3.67M Sell
68,584
-4,206
-6% -$218K 0.53% 41
2020
Q3
$3.42M Sell
72,790
-3,609
-5% -$185K 0.59% 41
2020
Q2
$3.99M Sell
76,399
-802
-1% -$41.3K 0.74% 34
2020
Q1
$3.7M Buy
77,201
+4,578
+6% +$238K 0.82% 34
2019
Q4
$3.67M Sell
72,623
-2,519
-3% -$130K 0.6% 41
2019
Q3
$3.55M Sell
75,142
-2,325
-3% -$106K 0.59% 40
2019
Q2
$3.65M Sell
77,467
-645
-0.8% -$29.8K 0.64% 37
2019
Q1
$3.76M Buy
78,112
+3,318
+4% +$166K 0.68% 35
2018
Q4
$3.34M Sell
74,794
-1,731
-2% -$90.2K 0.68% 36
2018
Q3
$4.13M Sell
76,525
-1,274
-2% -$65.2K 0.7% 33
2018
Q2
$3.8M Buy
77,799
+8,748
+13% +$496K 0.81% 33
2018
Q1
$4.33M Buy
69,051
+15,675
+29% +$1.08M 0.86% 29
2017
Q4
$3.27M Sell
53,376
-28,683
-35% -$1.77M 0.67% 35
2017
Q3
$5.49M Buy
82,059
+3,520
+4% +$249K 1.2% 22
2017
Q2
$6.12M Buy
78,539
+3,221
+4% +$243K 1.37% 18
2017
Q1
$6.14M Buy
75,318
+3,575
+5% +$281K 1.38% 18
2016
Q4
$5.16M Buy
71,743
+313
+0.4% +$22.6K 1.24% 21
2016
Q3
$5.55M Buy
71,430
+275
+0.4% +$22.2K 1.43% 16
2016
Q2
$5.55M Buy
71,155
+3,608
+5% +$288K 1.45% 17
2016
Q1
$5.54M Sell
67,547
-1,206
-2% -$98.1K 1.52% 16
2015
Q4
$6.14M Buy
68,753
+5,300
+8% +$450K 1.85% 10
2015
Q3
$4.87M Sell
63,453
-150
-0.2% -$12.5K 1.55% 14
2015
Q2
$5.31M Sell
63,603
-1,250
-2% -$110K 1.62% 15
2015
Q1
$5.85M Hold
64,853
1.73% 12
2014
Q4
$5.24M Sell
64,853
-4,023
-6% -$318K 1.52% 16
2014
Q3
$5.16M Buy
68,876
+1,775
+3% +$129K 1.48% 18
2014
Q2
$4.6M Sell
67,101
-50
-0.1% -$3.4K 1.32% 23
2014
Q1
$4.7M Sell
67,151
-250
-0.4% -$17.4K 1.45% 22
2013
Q4
$4.5M Sell
67,401
-600
-0.9% -$36.7K 1.41% 19
2013
Q3
$3.55M Buy
+68,001
New +$3.45M 1.23% 26

Other funds holding CAH

First Nebraska Trust's CAH Position: Q1 2026 in Review

First Nebraska Trust reduced its Cardinal Health (CAH) stake by 2.1% in Q1 2026, selling an estimated $398K and leaving 85,056 shares worth $18M. The position accounts for 1.66% of the portfolio, ranked #13.

First Nebraska Trust first reported a position in CAH in Q3 2013 and has held it in 51 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • First Nebraska Trust held 85,056 shares of Cardinal Health worth $18M as of Q1 2026.
  • First Nebraska Trust sold 1,849 Cardinal Health shares in Q1 2026, an estimated $398K.
  • Cardinal Health made up 1.66% of First Nebraska Trust's portfolio in Q1 2026, its #13 holding.
  • First Nebraska Trust first reported a position in Cardinal Health in Q3 2013 and has held it in 51 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.